T. Rowe Price Associates
GRDN

T. Rowe Price Associates’s Guardian Pharmacy Services GRDN Stock Holding History

T. Rowe Price Associates’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$600K Sell
14,323
-1,841
-11% -$71.3K ﹤0.01% 2538
2026
Q1 		$609K Buy
16,164
+4,279
+36% +$140K ﹤0.01% 2364
2025
Q4 		$358K Buy
11,885
+1,409
+13% +$39.9K ﹤0.01% 2555
2025
Q3 		$275K Buy
+10,476
New +$250K ﹤0.01% 2641

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

T. Rowe Price Associates's GRDN Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Guardian Pharmacy Services (GRDN) stake by 11% in Q2 2026, selling an estimated $71.3K and leaving 14,323 shares worth $600K. The position accounts for ﹤0.01% of the portfolio, ranked #2538.

T. Rowe Price Associates first reported a position in GRDN in Q3 2025 and has held it in 4 quarters since. The position peaked at $609K in Q1 2026. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • T. Rowe Price Associates held 14,323 shares of Guardian Pharmacy Services worth $600K as of Q2 2026.
  • T. Rowe Price Associates sold 1,841 Guardian Pharmacy Services shares in Q2 2026, an estimated $71.3K.
  • Guardian Pharmacy Services made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2538 holding.
  • T. Rowe Price Associates first reported a position in Guardian Pharmacy Services in Q3 2025 and has held it in 4 quarters since.
  • T. Rowe Price Associates's Guardian Pharmacy Services position peaked at $609K in Q1 2026.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.